MAN 01 companion diagnostic - Q BioMed/Washington University in St. Louis

Drug Profile

MAN 01 companion diagnostic - Q BioMed/Washington University in St. Louis

Alternative Names: GDF 15 companion diagnostic - Q Biomed/Washington University in St. Louis

Latest Information Update: 20 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Washington University
  • Developer Q BioMed; Washington University
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Glaucoma

Most Recent Events

  • 08 Feb 2018 Q BioMed in-licenses GDF 15 from Washington University in St. Louis
  • 08 Feb 2018 Preclinical trials in Glaucoma (Diagnosis) in USA (unspecified route)
  • 08 Feb 2018 Interim pharmacodynamics data from preclinical study in Glaucoma (diagnosis) released by Q BioMed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top